BLT 0.00% 2.6¢ benitec biopharma limited

Gradalis about to start NSCLC trial, page-5

  1. 653 Posts.
    lightbulb Created with Sketch. 10
    Mesoblast released data without "releasing" data, the post referenced should not have been moderated as it was relevant to the situation BLT holders find themselves in. Mesoblast is light years ahead of BLT in knowing how to create value. Should fire some messages to the company highlighting how Mesoblast is getting it done.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.